|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| A61K 31/713 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 2836595 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13721433.4 |
| Date of filing the European patent application | 2013-04-10 | |
| (97) | Date of publication of the European application | 2015-02-18 |
| (45) | Date of publication and mention of the grant of the patent | 2017-06-14 |
| (46) | Date of publication of the claims translation | 2017-09-25 |
| (86) | Number | PCT/US2013/036006 |
| Date | 2013-04-10 |
| (87) | Number | WO 2013/155204 |
| Date | 2013-10-17 |
| (30) | Number | Date | Country code |
| 201261622288 P | 2012-04-10 | US | |
| 201313835613 | 2013-03-15 | US |
| (72) |
BETTENCOURT, Brian, US
FITZGERALD, Kevin, US
QUERBES, William, US
YASUDA, Makiko, US
DESNICK, Robert, J., US
|
| (73) |
Alnylam Pharmaceuticals, Inc.,
300 Third Street, Cambridge, MA 02142,
US
Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, US |
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Kompozicijos ir būdai, skirti ALAS1 geno raiškos slopinimui |
| COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE |
| Payment date | Validity (years) | Amount | |
| 2025-03-25 | 13 | 289.00 EUR |
| 2026-04-10 |